Related Experiment Video
Updated: Feb 13, 2026

Preparation of 2-dGuo-Treated Thymus Organ Cultures
Published on: August 28, 2008
Targeting IL-2: an unexpected effect in treating immunological diseases
Congxiu Ye1, David Brand2, Song G Zheng1,3
11Department of Clinical Immunology, Third Affiliated Hospital at Sun Yat-sen University, Guangzhou, China.
Low-dose Interleukin-2 (IL-2) therapy shows promise for autoimmune diseases by promoting regulatory T cell (Treg) development and function. Clinical trials demonstrate its potential for safe and effective immune tolerance induction.
Area of Science:
- Immunology
- Autoimmune Diseases
- Cellular Biology
Background:
- Regulatory T cells (Tregs) are vital for immune homeostasis; their dysfunction is linked to autoimmune and inflammatory conditions.
- Interleukin-2 (IL-2) traditionally promotes T-cell proliferation but low-dose IL-2 unexpectedly induces immune tolerance.
Purpose of the Study:
- To review the biological mechanisms of IL-2 signaling in Treg development and function.
- To summarize clinical evidence supporting low-dose IL-2 therapy for autoimmune disorders.
Main Methods:
- Review of existing literature on IL-2 biology and Treg cell function.
- Analysis of proof-of-concept clinical trial data for low-dose IL-2 in autoimmune diseases.
Main Results:
- Low-dose IL-2 therapy effectively expands and activates Tregs, suppressing aberrant immune responses.
- Clinical trials indicate that low-dose IL-2 can safely control autoimmune diseases.
Conclusions:
- Low-dose IL-2 represents a promising therapeutic strategy for autoimmune diseases by enhancing Treg function.
- Further well-controlled clinical trials are necessary to optimize dosing strategies and validate IL-2/anti-cytokine complexes.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
2° Amines to N-Nitrosamines: Reaction with NaNO2
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
SN2 Reaction: Kinetics
In a chemical reaction, a relationship exists between the concentration of reactants and the rate at which the reaction proceeds. The study to measure this relationship is known as the kinetics of a chemical reaction. Kinetic studies are used to deduce the rate law of a chemical reaction, which provides information about the species involved during the transition state of the rate-determining step. Thus, kinetic studies help to derive the mechanism of a...
SN2 Reaction: Mechanism
The presence of the more electronegative halogen in the substrate creates a polarized carbon-halide bond. The halide pulls the electron cloud generating an electrophilic center at the carbon atom. Thus, the carbon atom carries a partial positive charge while the halide has a...

